New survey on spray to delay ejaculation

Spray to delay ejaculation has been developed by scientists at the Royal Victoria Hospital in Belfast, Ireland. This product is designed for men suffering from premature ejaculation. Men with premature ejaculation problems have  multiplied the time of their sexual relationship by six with the PSD502 (Premature Ejaculation Spray).

Professor Dinsmore and colleagues at the Royal Victoria Hospital in Belfast in Northern Ireland have completed their study of 300 men suffering from premature ejaculation and have developed a spray called Premature Ejaculation Spray (PSD502), which applies on the penis about 5 minutes before intercourse. Their study was published in the  Journal of the British Association of Urological Surgeons.

Some men in this study reached orgasm before one minute, or even before penetration. For three months they were followed in 31 hospitals in the United Kingdom, Czech Republic, Hungary and Poland.

They were divided into two groups. A first group of 200 men used the PSD502 spray containing 7.5 mg of lidocaine and 2.5mg of prilocaine. The second group of 100 people used a placebo spray without active ingredients.

During the three months of the study, each couple had to measure the time between vaginal penetration and ejaculation. The men were asked to refrain from masturbation to avoid compromising the results of the study.

The time between penetration and ejaculation has gradually increased from an average of 0.6 minutes to 3.8 minutes in the group that used the spray PSD502 and only to 1.1 minutes in the placebo group.

Thus, the time of intercourse of PSD502 spray users has been multiplied by six. It appears from these results that the time of intercourse for 90% of men using PSD502 increased from a few seconds to at least four minutes. It is true that it is insufficient for a woman, but it's a good start.

"Premature ejaculation can be very distressing for men," said Professor W. Wallace Dinsmore from the Royal Victoria Hospital in Belfast in Northern Ireland.

• Soon a vaccine against malaria for the pregnant?
• Allergy: New in treatment
• Multiple sclerosis: the benefits of exercise
• Babies learn bilingualism from the womb
• Stuttering has genetic origin
• Genetic variants accelerate biological aging
• Chronic cough: Pepper to refine the diagnosis
• The intestinal flora, a "black box" to explore